Hinge Health, Inc.
HNGE
$54.06
-$1.16-2.10%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.78% | 50.58% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.78% | 50.58% | -- | -- | -- |
| Cost of Revenue | 37.59% | 30.97% | -- | -- | -- |
| Gross Profit | 52.96% | 56.50% | -- | -- | -- |
| SG&A Expenses | 186.84% | 179.88% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 180.21% | 168.56% | -- | -- | -- |
| Operating Income | -4,275.74% | -1,611.15% | -- | -- | -- |
| Income Before Tax | -1,949.01% | -5,509.78% | -- | -- | -- |
| Income Tax Expenses | -46.34% | 47.42% | -- | -- | -- |
| Earnings from Continuing Operations | -2,040.15% | -5,199.88% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,040.15% | -5,199.88% | -- | -- | -- |
| EBIT | -4,275.74% | -1,611.15% | -- | -- | -- |
| EBITDA | -3,632.85% | -1,739.88% | -- | -- | -- |
| EPS Basic | -237.45% | -407.59% | -- | -- | -- |
| Normalized Basic EPS | -640.64% | -1,213.23% | -- | -- | -- |
| EPS Diluted | -627.44% | -1,104.06% | -- | -- | -- |
| Normalized Diluted EPS | -1,074.75% | -1,298.50% | -- | -- | -- |
| Average Basic Shares Outstanding | 400.06% | 301.33% | -- | -- | -- |
| Average Diluted Shares Outstanding | 112.16% | 424.68% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |